Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
M6rUwvSg30hhpYgt
Listen
